| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 20.00M | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, MAZE returned +118.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -29.0% |
| 1 year | +118.2% |
| All-time high | $45.59 (Feb 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in MAZE would be worth today ›No. Maze Therapeutics, Inc. has not paid a dividend in the past 12 months.
Maze Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol MAZE.
Maze Therapeutics, Inc. is part of the Healthcare sector.
Maze Therapeutics, Inc. has a market cap of 1.63B USD, based on the latest quote.
Maze Therapeutics, Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
